Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pacira Pharm Inc (PCRX)

Pacira Pharm Inc (PCRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,461,918
  • Shares Outstanding, K 44,455
  • Annual Sales, $ 429,650 K
  • Annual Income, $ 145,520 K
  • 60-Month Beta 1.07
  • Price/Sales 5.79
  • Price/Cash Flow 25.51
  • Price/Book 3.65
Trade PCRX with:

Options Overview

Details
  • Implied Volatility 47.14%
  • Historical Volatility 27.78%
  • IV Percentile 30%
  • IV Rank 38.16%
  • IV High 76.74% on 02/24/21
  • IV Low 28.88% on 06/02/21
  • Put/Call Vol Ratio 0.52
  • Today's Volume 50
  • Volume Avg (30-Day) 95
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 371
  • Open Int (30-Day) 421

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.51
  • Number of Estimates 5
  • High Estimate 0.67
  • Low Estimate 0.45
  • Prior Year 0.43
  • Growth Rate Est. (year over year) +18.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
53.75 +3.03%
on 09/14/21
60.44 -8.37%
on 09/01/21
-1.03 (-1.83%)
since 08/20/21
3-Month
53.75 +3.03%
on 09/14/21
64.05 -13.54%
on 06/25/21
-4.26 (-7.14%)
since 06/18/21
52-Week
48.23 +14.82%
on 10/29/20
80.00 -30.77%
on 02/25/21
-5.39 (-8.87%)
since 09/18/20

Most Recent Stories

More News
Pacira BioSciences Reports Preliminary Net Product Sales of $42.3 Million for August 2021

-- Expanding EXPAREL utilization continues to drive growth with average daily sales at 109% of August 2020 --

PCRX : 55.38 (-1.00%)
Pacira BioSciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the H.C. Wainwright 23 Annual Global Investment Conference at 7:00 AM ET on Monday, September 13, 2021. Pre-recorded audio...

PCRX : 55.38 (-1.00%)
Pacira (PCRX) Down 1.6% Since Last Earnings Report: Can It Rebound?

Pacira (PCRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PCRX : 55.38 (-1.00%)
Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported preliminary unaudited net product sales of...

PCRX : 55.38 (-1.00%)
Pacira's (PCRX) Q2 Earnings Beat Estimates, Revenues Rise Y/Y

Pacira's (PCRX) earnings and revenues in the second quarter of 2021 surpass estimates. Exparel sales surge year over year.

IRWD : 12.35 (unch)
PCRX : 55.38 (-1.00%)
CANF : 1.7000 (-2.30%)
TBPH : 6.88 (-3.23%)
Pacira BioSciences to Present at the 2021 Wedbush PacGrow Healthcare Virtual Conference

Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2021 Wedbush PacGrow Healthcare Virtual Conference at 10:20 AM ET on Tuesday, August 10, 2021. Live audio of the virtual...

PCRX : 55.38 (-1.00%)
Pacira (PCRX) Q2 Earnings Surpass Estimates

Pacira (PCRX) delivered earnings and revenue surprises of 1.32% and -0.01%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

PCRX : 55.38 (-1.00%)
Pacira: Q2 Earnings Snapshot

PARSIPPANY, N.J. (AP) _ Pacira Pharmaceuticals Inc. (PCRX) on Tuesday reported second-quarter net income of $19.1 million, after reporting a loss in the same period a year earlier.

PCRX : 55.38 (-1.00%)
Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021

-- EXPAREL average daily sales at 178% of the prior year second quarter --

PCRX : 55.38 (-1.00%)
Pacira Announces FDA Approval of Enhanced EXPAREL Manufacturing Process

-- New 200-liter suite doubles capacity to meet growing EXPAREL demand --

PCRX : 55.38 (-1.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Pacira Pharmaceuticals, Inc....

See More

Key Turning Points

3rd Resistance Point 56.74
2nd Resistance Point 56.07
1st Resistance Point 55.72
Last Price 55.38
1st Support Level 54.70
2nd Support Level 54.03
3rd Support Level 53.68

See More

52-Week High 80.00
Fibonacci 61.8% 67.86
Fibonacci 50% 64.11
Fibonacci 38.2% 60.37
Last Price 55.38
52-Week Low 48.23

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar